Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyLactate shuttles at a glance: from physiological paradigms to anti-cancer treatmentsMultivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostatesQuantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.Synaptosomal lactate dehydrogenase isoenzyme composition is shifted toward aerobic forms in primate brain evolution.Anticancer targets in the glycolytic metabolism of tumors: a comprehensive reviewOn-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate.Lactate dehydrogenase-B is silenced by promoter methylation in a high frequency of human breast cancers.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANAInhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma: Strobe-Compliant Article.Anticancer agents that counteract tumor glycolysis.Serum lactate dehydrogenase and survival following cancer diagnosis.LDHB may be a significant predictor of poor prognosis in osteosarcoma.Prostate cancer: the need for biomarkers and new therapeutic targets.Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.Small-molecule inhibitors of human LDH5.Proteomics revisits the cancer metabolome.Targeting lactate metabolism for cancer therapeutics.Metabolic modulation of cancer: a new frontier with great translational potential.Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype.NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells.Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.Helicobacter pylori outer inflammatory protein A (OipA) suppresses apoptosis of AGS gastric cells in vitro.11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs.Aberrant FGFR tyrosine kinase signaling enhances the Warburg effect by reprogramming LDH isoform expression and activity in prostate cancer.
P2860
Q26766079-78F0BBB5-AE47-46D9-B79B-3E58FD2555DFQ26863243-15634F14-002F-49F9-AA6B-BD60A52A3404Q33389634-99057792-CABF-4741-B6BA-8FDF758DDB51Q33697764-10788E97-A89A-4D76-927A-51F1BD7156B6Q33816045-8C0A01E1-0937-4A10-AA9D-E3437B5F971FQ33824237-5D2908AB-D98F-40B2-8082-9047CCCD3845Q33897286-7B02F212-EC76-49A9-9879-1C4177B706B0Q34028478-AA15919C-FDB2-4CE0-9ACF-9CD13A5F9FC6Q34498003-2EBD6031-EF32-4863-B8D7-36CE79E331D2Q34600639-A8F7EFD3-EB25-44D2-857D-59CF19A919D1Q34958895-506C2183-8A24-402F-9E6E-9DD54FA5F1A8Q35080754-81D08CDF-3681-42CB-A412-6076D4D03F80Q35176109-C1FBD6E1-FF35-48CE-9B8C-140A7E45A22CQ35636543-2E8BFDD9-5216-47F0-9B24-E00AAECFC7D7Q36195789-EA1DC7B3-2640-4CEB-9C92-CD64DE50A72BQ36452381-0299B80B-1659-46B8-9516-C062F5C0828DQ36750612-B3F5C2F2-5CCB-406B-BFC4-94338CB130C6Q37448160-56DA4BCF-B44F-4BE5-ACA4-424F035C2D00Q37476043-833FF6BB-89A4-44BA-9748-ACE387235760Q37481324-8440DF76-48E1-40BE-9F89-E5533E74A5E3Q37634356-71FE1F71-E289-4C54-9365-CD5E32C2D8A6Q37912205-0128E390-C63A-48AF-B7F2-DBBEAAF22B1AQ38133722-D46E6D94-EB05-42AE-99F3-C310AE8C6113Q38317294-BF4C8667-D776-4206-8DB5-F428D4A26FC2Q38882978-B5A12E0C-6765-465F-BA5B-6E6BA2388C58Q38895387-161DFB73-2DE5-43CE-B556-15F6877E0476Q39014515-0ACC43D8-2FB5-4E1A-A00C-5C58A05468ACQ39312047-217C0FDA-2F52-40E8-810A-3683EA0C5959Q40106922-6DC55111-05D4-4EC5-8E38-7793FE352A29Q47433431-9A96E2EC-8AA2-4D90-A672-E65EC05F52B0Q49188115-9ACB08A0-D17D-459D-9075-4975BC6324E3Q54976511-ABAAB35A-C379-4815-BF24-9BEE1A18943D
P2860
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Lactate dehydrogenase-B is sil ...... tion in human prostate cancer.
@en
type
label
Lactate dehydrogenase-B is sil ...... tion in human prostate cancer.
@en
prefLabel
Lactate dehydrogenase-B is sil ...... tion in human prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Lactate dehydrogenase-B is sil ...... tion in human prostate cancer.
@en
P2093
A Leiblich
J T Phillips
J W F Catto
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209262
P407
P577
2006-05-01T00:00:00Z
P5875
P6179
1010937014